回复：今又生Gendicine --中国抗癌药品

It is so intersting that WP is bring this old news up again (your cited article). That makes you wonder which PR firm is paying foe the media companies recently.

There is NO NSCLC trial data on this drug. It requires imaging guired injection into the tumor mass which is not as easy as the head&neck cancer treatment Dr. Peng has been doing.